Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) [Phase 1]
This update reports the completion of a Phase 1 study (DUET-3) evaluating XmAb23104 in patients with selected advanced solid tumors.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations [Phase 1]
A Phase 1 clinical trial evaluating IX001 TCR-T therapy for advanced pancreatic cancer and KRAS-mutant colorectal cancer is currently recrui…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
This entry notes an ongoing clinical trial funded by Fudan University to evaluate a multi-omics model using circulating-free DNA for pancrea…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical study evaluating Adebrelimab combined with decitabine, albumin-bound paclitaxel, and gemcitabine as first-line therapy …
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer [NA]
A recruiting clinical trial is evaluating the safety and efficacy of the BGT007H cell therapy for patients with relapsed or refractory pancr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06952229 in adults with advanced solid tumors was terminated. Results were posted on 2024-06-26.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: GPC3/Mesothelin-CAR-γδT Cells Against Cancers [Phase 1]
Phase 1 clinical trial evaluating GPC3/Mesothelin-CAR-γδT cells for pancreatic, lung, liver cancers and mesothelioma; currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers [Phase 1]
Phase 1 clinical trial assessing mesothelin/GPC3/GUCY2C-targeted CAR-T cells for pancreatic cancer and other solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients [Phase 2]
Phase 2 clinical trial status update for a PD-1 inhibitor combined with chemotherapy and PULSAR in locally advanced and recurrent pancreatic…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a triplex checkpoint inhibitor therapy evaluating safety and efficacy in advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
-
CLINICAL_TRIALS withdrawal · 2024-06-21Clinical Trial Update: Pilot Study of 89-Zr Panitumumab in Pancreas Cancer [Phase 1]
A Phase 1 pilot study of Zirconium-89 labeled Panitumumab for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Role of Pre-operative CPET in Pancreatoduodenectomy
A completed clinical trial evaluating the role of pre-operative CPET in patients undergoing pancreatoduodenectomy for pancreatic and periamp…
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Signature for Precise Chemosensitivity Prediction in PDAC
A clinical trial evaluating a signature for precise chemosensitivity prediction in pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Azeliragon for metastatic pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating surufatinib combined with KN046 and AG regimen chemotherapy as first-line treatment for unresect…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Whipples Resection in Octogenarians
A clinical trial update on Whipple's resection in octogenarians with pancreatic cancer. The trial status is completed.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness [Phase 4]
A Phase 4 clinical trial is evaluating a pharmacokinetic boosting strategy for olaparib to improve exposure and tolerability, with a focus o…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer [EARLY_Phase 1]
A Phase 1 imaging trial evaluating in vivo PARP-1 expression with the PET tracer 18F-FTT in pancreatic cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care [NA]
The clinical trial evaluating acupuncture and Chinese herbal medicine in palliative care for cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy [Phase 1, Phase 2]
An update on the QUILT-3.039 Phase 1/2 trial evaluating ImmunityBio's NANT Pancreatic Cancer Vaccine in combination immunotherapy for pancre…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients [NA]
The pancreatic cancer trial evaluating a breath-hold technique during SBRT has been terminated.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline
This prospective registry of patients with resectable and borderline resectable pancreatic cancer has completed data collection.